14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes

Journal of Cell Science

Volumn 126, Issue 18, 2013, Pages 4173-4186

  Xu, Zhe ^a   Graham, Kourtney ^a   Foote, Molly ^a   Liang, Fengshan ^a   Rizkallah, Raed ^a   Hurt, Myra ^a   Wang, Yanchang ^a   Wu, Yuying ^a   Zhou, Yi ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adaptor; Aggresome 14 3 3; BAG3; Dynein

Indexed keywords

BAG 3 PROTEIN; CHAPERONE ASSOCIATED PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DYNEIN ADENOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 70; PROTEIN; PROTEIN 14 3 3; UNCLASSIFIED DRUG;

AGGRESOME; ANIMAL CELL; ARTICLE; CELL INCLUSION; CELLULAR DISTRIBUTION; CENTROSOME; CONTROLLED STUDY; DELETION MUTANT; DIMERIZATION; DROSOPHILA; LEWY BODY; MAMMAL CELL; MICROTUBULE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; YEAST CELL;

14-3-3; ADAPTOR; AGGRESOME; BAG3; DYNEIN;

14-3-3 PROTEINS; DYNEINS; MOLECULAR CHAPERONES; PROTEIN FOLDING; PROTEINS; TRANSFECTION;

EID: 84885444527     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.126102     Document Type: Article

References (63)

1. Aitken, A. (2002). Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol. Biol. 50, 993-1010.
2. Boston, P. F., Jackson, P. and Thompson, R. J. (1982). Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J. Neurochem. 38, 1475-1482.
3. Chen, H. K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M., Orr, H. T., Botas, J. et al. (2003). Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113, 457-468.
4. Chin, L. S., Olzmann, J. A. and Li, L. (2010). Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem. Soc. Trans. 38, 144-149.
5. Datta, S. R., Katsov, A., Hu, L., Petros, A., Fesik, S. W., Yaffe, M. B. and Greenberg, M. E. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6, 41-51.
6. Fantl, W. J., Muslin, A. J., Kikuchi, A., Martin, J. A., MacNicol, A. M., Gross, R. W. and Williams, L. T. (1994). Activation of Raf-1 by 14-3-3 proteins. Nature 371, 612-614.
7. Foote, M. and Zhou, Y. (2012). 14-3-3 proteins in neurological disorders. Int. J. Biochem Mol. Biol. 3, 152-164.
8. Fu, H., Subramanian, R. R. and Masters, S. C. (2000). 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617-647.
9. Furukawa, Y., Ikuta, N., Omata, S., Yamauchi, T., Isobe, T. and Ichimura, T. (1993). Demonstration of the phosphorylation-dependent interaction of tryptophan hydroxylase with the 14-3-3 protein. Biochem. Biophys. Res. Commun. 194, 144-149.
10. Gamerdinger, M., Hajieva, P., Kaya, A. M., Wolfrum, U., Hartl, F. U. and Behl, C. (2009). Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 28, 889-901.
11. Gamerdinger, M., Kaya, A. M., Wolfrum, U., Clement, A. M. and Behl, C. (2011). BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins. EMBO Rep. 12, 149-156.
12. García-Mata, R., Bebök, Z., Sorscher, E. J. and Sztul, E. S. (1999). Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146, 1239-1254.
13. Garcia-Mata, R., Gao, Y. S. and Sztul, E. (2002). Hassles with taking out the garbage: aggravating aggresomes. Traffic 3, 388-396.
14. Ge, F., Li, W. L., Bi, L. J., Tao, S. C., Zhang, Z. P. and Zhang, X. E. (2010a). Identification of novel 14-3-3f interacting proteins by quantitative immunoprecipitation combined with knockdown (QUICK). J. Proteome Res. 9, 5848-5858.
15. Ge, F., Xiao, C. L., Bi, L. J., Tao, S. C., Xiong, S., Yin, X. F., Li, L. P., Lu, C. H., Jia, H. T. and He, Q. Y. (2010b). Quantitative phosphoproteomics of proteasome inhibition in multiple myeloma cells. PLoS ONE 5, e13095.
16. Hashiguchi, M., Sobue, K. and Paudel, H. K. (2000). 14-3-3zeta is an effector of tau protein phosphorylation. J. Biol. Chem. 275, 25247-25254.
17. Johnston, J. A., Ward, C. L. and Kopito, R. R. (1998). Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898.
18. Kaneko, K. and Hachiya, N. S. (2006). The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions. Med. Hypotheses 67, 169-171.
19. Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A. and Yao, T. P. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727-738.
20. Kawamoto, Y., Akiguchi, I., Nakamura, S., Honjyo, Y., Shibasaki, H. and Budka, H. (2002). 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J. Neuropathol. Exp. Neurol. 61, 245-253.
21. Kawamoto, Y., Akiguchi, I., Nakamura, S. and Budka, H. (2004). 14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 108, 531-537.
22. Kopito, R. R. (2000). Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530.
23. Liu, D., Bienkowska, J., Petosa, C., Collier, R. J., Fu, H. and Liddington, R. (1995). Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376, 191-194.
24. Masters, S. C. and Fu, H. (2001). 14-3-3 proteins mediate an essential anti-apoptotic signal. J. Biol. Chem. 276, 45193-45200.
25. McLean, P. J., Kawamata, H. and Hyman, B. T. (2001). Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104, 901-912.
26. Messaritou, G., Grammenoudi, S. and Skoulakis, E. M. (2010). Dimerization is essential for 14-3-3zeta stability and function in vivo. J. Biol. Chem. 285, 1692-1700.
27. Moore, B. W. and Perez, V. J. (1967). Specific acidic proteins of the nervous system. In Physiological and Biochemical Aspects of Nervous Integration (ed. F.D. Carlson), pp. 343-359. Englewood Cliffs, NJ: Prentice-Hall.
28. Muslin, A. J., Tanner, J. W., Allen, P. M. and Shaw, A. S. (1996). Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889-897.
29. Olzmann, J. A., Li, L., Chudaev, M. V., Chen, J., Perez, F. A., Palmiter, R. D. and Chin, L. S. (2007). Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol. 178, 1025-1038.
30. Omi, K., Hachiya, N. S., Tanaka, M., Tokunaga, K. and Kaneko, K. (2008). 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Neurosci. Lett. 431, 45-50.
31. Opazo, F., Krenz, A., Heermann, S., Schulz, J. B. and Falkenburger, B. H. (2008). Accumulation and clearance of alpha-synuclein aggregates demonstrated by timelapse imaging. J. Neurochem. 106, 529-540.
32. Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J. and Wolozin, B. (1999). alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782-5791.
33. Palmer, K. J., Hughes, H. and Stephens, D. J. (2009). Specificity of cytoplasmic dynein subunits in discrete membrane-trafficking steps. Mol. Biol. Cell 20, 2885-2899.
34. Peng, C. Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S. and Piwnica-Worms, H. (1997). Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
35. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C. J., Brown, S. D. and Rubinsztein, D. C. (2005). Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 37, 771-776.
36. Richard, M., Biacabe, A. G., Streichenberger, N., Ironside, J. W., Mohr, M., Kopp, N. and Perret-Liaudet, A. (2003). Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathol. 105, 296-302.
37. Rittinger, K., Budman, J., Xu, J., Volinia, S., Cantley, L. C., Smerdon, S. J., Gamblin, S. J. and Yaffe, M. B. (1999). Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell 4, 153-166.
38. Rosenquist, M., Sehnke, P., Ferl, R. J., Sommarin, M. and Larsson, C. (2000). Evolution of the 14-3-3 protein family: does the large number of isoforms in multicellular organisms reflect functional specificity?. J. Mol. Evol. 51, 446-458.
39. Ross, C. A. and Poirier, M. A. (2005). Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6, 891-898.
40. Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N. and Tanaka, K. (2006). 14-3-3eta is a novel regulator of parkin ubiquitin ligase. EMBO J. 25, 211-221.
41. Shen, Y. H., Godlewski, J., Bronisz, A., Zhu, J., Comb, M. J., Avruch, J. and Tzivion, G. (2003). Significance of 14-3-3 self-dimerization for phosphorylationdependent target binding. Mol. Biol. Cell 14, 4721-4733.
42. Skoulakis, E. M. and Davis, R. L. (1998). 14-3-3 proteins in neuronal development and function. Mol. Neurobiol. 16, 269-284.
43. Sluchanko, N. N., Artemova, N. V., Sudnitsyna, M. V., Safenkova, I. V., Antson, A. A., Levitsky, D. I. and Gusev, N. B. (2012). Monomeric 14-3-3f has a chaperonelike activity and is stabilized by phosphorylated HspB6. Biochemistry 51, 6127-6138.
44. Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T. and Mouradian, M. M. (2004). Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 4625-4631.
45. Tyedmers, J., Mogk, A. and Bukau, B. (2010). Cellular strategies for controlling protein aggregation. Nat. Rev. Mol. Cell Biol. 11, 777-788.
46. Tzivion, G. and Avruch, J. (2002). 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277, 3061-3064.
47. Tzivion, G., Luo, Z. and Avruch, J. (1998). A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394, 88-92.
48. Ubl, A., Berg, D., Holzmann, C., Krüger, R., Berger, K., Arzberger, T., Bornemann, A. and Riess, O. (2002). 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. Brain Res. Mol. Brain Res. 108, 33-39.
49. Umahara, T., Uchihara, T., Tsuchiya, K., Nakamura, A., Iwamoto, T., Ikeda, K. and Takasaki, M. (2004). 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol. 108, 279-286.
50. Vincenz, C. and Dixit, V. M. (1996). 14-3-3 proteins associate with A20 in an isoformspecific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271, 20029-20034.
51. Wang, W. and Shakes, D. C. (1996). Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43, 384-398.
52. Wang, Y., Meriin, A. B., Zaarur, N., Romanova, N. V., Chernoff, Y. O., Costello, C. E. and Sherman, M. Y. (2009). Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J. 23, 451-463.
53. Watabe, M. and Nakaki, T. (2011). Protein kinase CK2 regulates the formation and clearance of aggresomes in response to stress. J. Cell Sci. 124, 1519-1532.
54. Williams, D. M., Ecroyd, H., Goodwin, K. L., Dai, H., Fu, H., Woodcock, J. M., Zhang, L. and Carver, J. A. (2011). NMR spectroscopy of 14-3-3f reveals a flexible C-terminal extension: differentiation of the chaperone and phosphoserine-binding activities of 14-3-3f. Biochem. J. 437, 493-503.
55. Xiao, B., Smerdon, S. J., Jones, D. H., Dodson, G. G., Soneji, Y., Aitken, A. and Gamblin, S. J. (1995). Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376, 188-191.
56. Xing, H., Zhang, S., Weinheimer, C., Kovacs, A. and Muslin, A. J. (2000). 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19, 349-358.
57. Yacoubian, T. A., Slone, S. R., Harrington, A. J., Hamamichi, S., Schieltz, J. M., Caldwell, K. A., Caldwell, G. A. and Standaert, D. G. (2010). Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis. 1, e2.
58. Yadav, S. and Linstedt, A. D. (2011). Golgi positioning. Cold Spring Harb. Perspect. Biol. 3, a005322.
59. Yano, M., Nakamuta, S., Wu, X., Okumura, Y. and Kido, H. (2006). A novel function of 14-3-3 protein: 14-3-3zeta is a heat-shock-related molecular chaperone that dissolves thermal-aggregated proteins. Mol. Biol. Cell 17, 4769-4779.
60. Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619-628.
61. Zhang, X. and Qian, S. B. (2011). Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes. Mol. Biol. Cell 22, 3277-3288.
62. Zhou, Y., Schopperle, W. M., Murrey, H., Jaramillo, A., Dagan, D., Griffith, L. C. and Levitan, I. B. (1999). A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel complex in Drosophila presynaptic nerve terminals. Neuron 22, 809-818.
63. Zhou, Y., Reddy, S., Murrey, H., Fei, H. and Levitan, I. B. (2003). Monomeric 14-3-3 protein is sufficient to modulate the activity of the Drosophila slowpoke calciumdependent potassium channel. J. Biol. Chem. 278, 10073-10080.